ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,080, issued on Jan. 28, was assigned to EQUINOX SCIENCES LLC (Wilmington, Del.).
"Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof" was invented by Congxin Liang (Palm Beach Gardens, Fla.) and Lihua Xie (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention discloses polymorphic forms of a compound of formula I, pharmaceutical compositions containing same, preparation method therefor and use thereof. The compound of formula I of the present invention is as shown in formula I, of which the crystalline form can be crystalline form 1, crystalline form...